Article
How to Capture the Bleeding Phenotype in FXI-Deficient Patients.
Hamostaseologie - 1 Nov 2020
Bertaggia Calderara Debora, Zermatten Maxime G, Aliotta Alessandro, Alberio Lorenzo
Abstract excerpt
Factor XI (FXI) is a serine protease involved in the propagation phase of coagulation and in providing clot stability. Several mutations in the F11 gene lead to FXI deficiency, a rare mild bleeding disorder. Current laboratory methods are unable to assess bleeding risk in FXI-deficient patients, because the degree of bleeding tendency does not correlate with plasma FXI activity as measured by routine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
